Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Cash-to-Debt : 0.18 (As of Jun. 2022)

View and export this data going back to 2024. Start your Free Trial

What is Singapore Institute Of Advanced Medicine Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Singapore Institute Of Advanced Medicine Holdings's cash to debt ratio for the quarter that ended in Jun. 2022 was 0.18.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Singapore Institute Of Advanced Medicine Holdings couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2022.

The historical rank and industry rank for Singapore Institute Of Advanced Medicine Holdings's Cash-to-Debt or its related term are showing as below:

SGX:9G2' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.11 Med: 0.17 Max: 0.18
Current: 0.17

During the past 3 years, Singapore Institute Of Advanced Medicine Holdings's highest Cash to Debt Ratio was 0.18. The lowest was 0.11. And the median was 0.17.

SGX:9G2's Cash-to-Debt is ranked worse than
72.46% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 0.69 vs SGX:9G2: 0.17

Singapore Institute Of Advanced Medicine Holdings Cash-to-Debt Historical Data

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Singapore Institute Of Advanced Medicine Holdings Cash-to-Debt Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data

Trend

Jun21

Jun22

Jun23

Cash-to-Debt

0.11

0.18

0.17

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
	Jun21	Jun22	Jun23
Cash-to-Debt	0.11	0.18	0.17

Competitive Comparison of Singapore Institute Of Advanced Medicine Holdings's Cash-to-Debt

For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Singapore Institute Of Advanced Medicine Holdings's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Institute Of Advanced Medicine Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Singapore Institute Of Advanced Medicine Holdings's Cash-to-Debt falls into.

Singapore Institute Of Advanced Medicine Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Singapore Institute Of Advanced Medicine Holdings's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	11.051	/	(13.112	+	50.899)
	=	0.17

Singapore Institute Of Advanced Medicine Holdings's Cash to Debt Ratio for the quarter that ended in Jun. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	15.839	/	(21.588	+	65.713)
	=	0.18

Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Singapore Institute Of Advanced Medicine Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Singapore Institute Of Advanced Medicine Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore Institute Of Advanced Medicine Holdings Ltd (SGX:9G2) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Singapore Institute Of Advanced Medicine Holdings Ltd is a healthcare service provider using advanced technology for early and accurate diagnosis, It is engaged in the following business segments Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services. Medical diagnostics and treatments which cover (i) cancer-related diagnostics and theranostics treatments; (ii) general diagnostics and health screening; and (iii) aesthetic services Medical diagnostics and treatments which cover (i) cancer-related diagnostics and theranostics treatments; (ii) general diagnostics and health screening; and (iii) aesthetic services. Maximum revenue is generated from generated from Medical Diagnostics and Treatments.

Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Headlines

No Headlines